TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer

scientific article

TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1043067162
P356DOI10.1186/1756-0500-4-215
P932PMC publication ID3141519
P698PubMed publication ID21702980
P5875ResearchGate publication ID51247698

P2093author name stringKeivan Majidzadeh-A
Nasrin Abdoli
Rezvan Esmaeili
P2860cites workAccurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genesQ24534395
FAST DB: a website resource for the study of the expression regulation of human gene productsQ24815689
Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancerQ25257296
De-regulation of common housekeeping genes in hepatocellular carcinomaQ27480955
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancerQ28297827
Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data setsQ29615465
Housekeeping genes in cancer: normalization of array dataQ30991810
Gene transcript assay by real-time RT-PCR in epithelial breast cancer cells selected by laser microdissection.Q31095034
Identification of genes for normalization of real-time RT-PCR data in breast carcinomasQ31143419
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patientsQ33179735
Breast cancer as a global health concern.Q50560105
Tech.Sight. A technique whose time has come.Q53671146
HER-2/neu gene copy number quantified by real-time PCR: comparison of gene amplification, heterozygosity, and immunohistochemical status in breast cancer tissue.Q54792338
Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patientsQ73907044
Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancerQ73967003
Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancerQ74523709
Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reactionQ84270183
Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patientsQ33190800
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancerQ33303529
Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancerQ33307453
Selection of REFERENCE genes for normalization of qRT-PCR data derived from FFPE breast tumorsQ33442804
A compendium of gene expression in normal human tissuesQ34107680
Breast cancer in the 21st century: neu opportunities and neu challengesQ34194240
Human housekeeping genes are compactQ34212688
The power of real-time PCR.Q34444172
Testing for HER-2/neu in breast cancer: is fluorescence in situ hybridization superior in predicting outcome?Q34985216
Breast cancer in Iran: an epidemiological review.Q36860896
The urokinase plasminogen activator system in cancer: a putative therapeutic target?Q37128728
Real time RT-PCR approach for the evaluation of ERBB2 overexpression in breast cancer archival samples: a comparative study with FISH, SISH, and immunohistochemistryQ38427140
Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.Q40023183
Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reactionQ40409287
Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes.Q40468240
Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patientsQ40492056
Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshopQ41162781
Identification of endogenous reference genes for qRT-PCR analysis in normal matched breast tumor tissuesQ43635727
Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogensQ44592481
Quantitative PCR--new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization.Q48348628
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectplasminogenQ107129060
P304page(s)215
P577publication date2011-06-25
P1433published inBMC Research NotesQ15762797
P1476titleTFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer
P478volume4

Reverse relations

cites work (P2860)
Q36939278A Comparison of Fresh Frozen vs. Formalin-Fixed, Paraffin-Embedded Specimens of Canine Mammary Tumors via Branched-DNA Assay
Q37684598AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer
Q30990983An unsupervised learning approach to find ovarian cancer genes through integration of biological data
Q33559365Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
Q38741790Clinical significance of NDRG3 in patients with breast cancer.
Q38085071Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target
Q35752868Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Q41447481G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin
Q36097570Genomic Alteration in Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Inferred from Karyotyping, Molecular Cytogenetics, and Array Comparative Genomic Hybridization.
Q38788262High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer.
Q51744639Identification of Suitable Reference Genes for mRNA Studies in Bone Marrow in a Mouse Model of Hematopoietic Stem Cell Transplantation.
Q35036620Identification of stable reference genes for gene expression analysis of three-dimensional cultivated human bone marrow-derived mesenchymal stromal cells for bone tissue engineering
Q35548593Identification of valid reference genes for the normalization of RT-qPCR expression studies in human breast cancer cell lines treated with and without transient transfection
Q33454439Iranian Breast Cancer Bio-Bank: the activity and challenging issues.
Q112641678MicroRNAs and their target mRNAs as potential biomarkers among smokers and non-smokers with lung adenocarcinoma
Q39429443Mutual enrichment in aggregated ranked lists with applications to gene expression regulation
Q27015506Quantification of HER family receptors in breast cancer
Q41996061Reference genes for expression studies in hypoxia and hyperglycemia models in human umbilical vein endothelial cells
Q30635987Selecting housekeeping genes as references for the normalization of quantitative PCR data in breast cancer
Q99726261Selecting suitable reference genes for qPCR normalization: a comprehensive analysis in MCF-7 breast cancer cell line
Q64975148Selection and Evaluation of Appropriate Reference Genes for RT-qPCR Normalization of Volvariella volvacea Gene Expression under Different Conditions.
Q47159979Study of the tumor microenvironment during breast cancer progression.

Search more.